Abstract OBJECTIVE: To study and identify the protein markers in the urine of children with steroid-sensitive (SSNS) and steroid-resistant nephrotic syndrome(SRNS). METHODS: Total urinary proteins were extracted from children with SSNS before and after steroid therapy, SRNS, and healthy children (n=5 in each group). Urinary proteins were separated by immobilized pH gradient based on two-dimensional gel electrophoresis (2-DE). The silver-stained 2-DE gels were scanned with digital Image Scanner and analyzed with Image Master 2-DE Elite 3.01 software. Peptide mass fingerprint (PMF) of differential protein spots was obtained with MALDI-TOF-MS. Proteins were identified by Mascot software based on NCBI protein database. RESULTS: There were 66 spots with different expression of protein between SRNS children and SSNS children before steroid therapy, and 24 spots and 27 spots only occurred in SRNS children and SSNS children before steroid therapy, respectively. There were 75 spots with different expression of protein between SSNS children after steroid therapy and healthy controls, and 11 spots only occurred in SSNS children after steroid therapy. Eighteen protein spots with different expression (6 spots in each nephrotic group) were chose and analyzed by MALDI-TOF-MS, and 9 types of proteins were identified. CONCLUSIONS: Nine types of urinary proteins with different expression (6 spots in each nephrotic group) were identified between SRNS and SSNS children, and they might be the biomarkers for SRNS or SSNS.［Chin J Contemp Pediatr, 2009, 11 (5):341-345］
HUANG Ai-Wen,HE Qing-Nan,ZHOU Pin et al. Preliminary analysis of urinary proteomics in children with steroidresistant and steroidsensitive nephrotic syndrome[J]. 中国当代儿科杂志, 2009, 11(05): 341-345.
HUANG Ai-Wen,HE Qing-Nan,ZHOU Pin et al. Preliminary analysis of urinary proteomics in children with steroidresistant and steroidsensitive nephrotic syndrome[J]. CJCP, 2009, 11(05): 341-345.
［5］Norris JL, Cornett DS, Mobley JA, Andersson M, Seeley EH, Chaurand P, et al. Processing MALDI Mass Spectra to Improve Mass Spectral Direct Tissue Analysis［J］. Int J Mass Spectrom, 2007, 260 (2-3):212-221.
［6］Dihazi H, Müller GA, Lindner S, Meyer M, Asif AR, Oellerich M, et al. Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients［J］. Clin Chem, 2007, 53(9):1636-1645.
［8］Abramowicz M, Barnett HL, Edelmann CM Jr, Greifer I, Kobayashi O, Arneil GC, et al. Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children［J］.Lancet, 1970, 1(7654):959-961.
［9］Behrman RE. Nelson Textbook of Pediatrics［M］. 16th ed. Philadephia: WB Sauders Co, 2000, 1500-1502.
［10］Misao J, Hayakawa Y, Ohno M, Kato S, Fujiwara T, Fujiwara H. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction ［J］.Circulation, 1996, 94(7):1506-1512.
［11］Rocha-Viegas L, Vicent GP, Baranao JL, Beato M, Pecci A. Glucocorticoids repress bcl-X expression in lymphoid cells by recruiting STAT5B to the P4 promoter［J］. Biol Chem, 2006, 281(45):33959-33970.
［12］Neuhaus TJ, Stallmach T, Genewein A. A boy with congenital analbu-minemia and steroid-sensitive idiopathic nephrotic syndrome: an experiment of nature ［J］. Eur Pediatr, 2008, 167(9):1073-1077.
［13］Ngai HH, Sit WH, Jiang PP, Thongboonkerd V, Wan JM. Markedly increased urinary preprohaptoglobin and haptoglobin in passive heymann nephritis: a differential proteomics approach［J］. Proteome Res, 2007, 6(8):3313-3320.
［14］Thongboonkerd V, Barati MT, McLeish KR, Benarafa C, RemoldO′Donnell E, Zheng S, et al. Alterations in the renal elastin-elastase system in type 1 diabetic nephropathy identified by proteomic analysis［J］. Am Soc Nephrol, 2004, 15(3):650-662.
［15］Weber MH, Verwiebe R. Alpha 1-microglobulin (protein HC): features of a promising indicator of proximal tubular dysfunction ［J］. Eur Clin Chem Biochem, 1992, 30(10):683-691.
［16］Imai H, Wakui H, Ishino T, Komatsuda A, Nakamoto Y, Miuri AB, et al. Glomerular deposition of complex-forming glycoprotein heterogenous in charge (protein HC) in IgA nephropathy［J］. Clin Nephrol, 1992, 37(4):169-176.
［17］Wakui H, Kobayashi R, Itoh H, Imai H, Nakamoto Y, Miuri AB, et al. High-yield purification of the complex-forming glycoprotein in urine from normal and abnormal subjects［J］. Clin Chem, 1989, 35(4):577-581.
